Phase II Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell)
Clinical trial NCT05770180 · COMPLETED
Trial details
- NCT number
- NCT05770180
- Sponsor
- WestVac Biopharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-30
- Primary completion
- 2023-07-30
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.